Popular products don’t pay off. Consistent ones do. You would have made 20% lower return if you simply chose popular products. PrimeInvestor will ensure you invest in the best.
You can save as much as 2% by going for direct plans. You don’t need to worry about going wrong because we’re here to tell you what to do and what not to.
Get on the driver's seat and take control. Let PrimeInvestor be the GPS for your financial journey!
Prime Blog Articles
Cut out the market noise. Stay on top of what's relevant to you.
Glenmark Life Sciences (GLS) is a generic API (Active Pharmaceutical Ingredients) manufacturer and a subsidiary of Glenmark Pharmaceuticals. The Glenmark Life Sciences IPO is worth Rs. 1,514 crore, comprising fresh issue of Rs.1,060 crore and an offer for sale worth Rs.454 crore by Glenmark Pharmaceuticals. Should you invest in the IPO of this high-value, non-commoditized API player?
There are certain characteristics which make evaluating banking and finance stocks different from others which produce goods and services. Money cannot be lent to someone unless there is an inflow by way of capital or debt. Since it is not practical to lend only from capital, borrowing (or leverage) is the sustaining food for this business. Naturally in using this leverage, there are good and bad apples.